Recipient

Alliance Pharmaceuticals Limited

First report 29 May 2018•Latest report 29 May 2018

Recipient record

Reports, concerns and published responses

Private and voluntary organisations · Private limited company. This page brings together reports naming this recipient and response statements clearly connected to concerns raised in those reports.

Reports
1

Naming this recipient

Published responses
100%

Found for named reports

Concerns addressed
3

Across all linked responses

Stated actions
9

Described in responses

Reports over time

Reports over time

Reports naming this recipient by issue year.

Evidence profile

Report topics

Share of this recipient’s reports compared with all other recipients.

100%published responses found
9stated actions described

Topic comparisons are not available in the current evidence snapshot.

Concerns and recipient responses

Statements from Alliance Pharmaceuticals Limited linked to the concerns in each report. Select any concern, action or position to view the source wording.

  1. West Yorkshire (Western)

    AI-generated summary

    Brian Leonard Bicat · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Brian Leonard Bicat sustained severe burns at home on 22 September 2017 when his dressing gown caught fire while he was smoking a cigarette. He died later that day from his extensive cutaneous burns, with evidence indicating that paraffin-based emollient creams and ointments increased the speed and intensity of the fire. The principal concerns were that low-paraffin emollients may pose a fire hazard, that warnings were not displayed consistently on packaging or communicated by healthcare professionals, and that related prescribing alerts and incident data were inconsistent or incomplete.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below. The report was sent to Alliance Pharmaceuticals Limited; that does not assign responsibility.

    PFD Monitor interpretation

    Unavailability of verbal fire-risk warnings from healthcare professionals for retail and online purchases

    Wider context from the report

    “Members of the public are able to purchase such products in retail outlets and online where verbal warnings from healthcare professionals are not given ”
    Open source report

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below. The report was sent to Alliance Pharmaceuticals Limited; that does not assign responsibility.

    PFD Monitor interpretation

    Lack of accurate national data on fire incidents involving paraffin-based skin products

    Wider context from the report

    “Consider a review of the current effectiveness of obtaining fire incident reports involving paraffin based skin products since there is currently a lack of accurate national data involving paraffin based skin products ”
    Open source report

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below. The report was sent to Alliance Pharmaceuticals Limited; that does not assign responsibility.

    PFD Monitor interpretation

    Inconsistent fire-risk alerts and warnings across NHS prescribing systems

    Wider context from the report

    “The NHS prescribing systems (system One and Optimise) appear to be updated by individual CCG’s resulting inconsistent alerts and warnings. ”
    Open source report

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below. The report was sent to Alliance Pharmaceuticals Limited; that does not assign responsibility.

    PFD Monitor interpretation

    Lack of healthcare professional awareness of the fire hazard from low-paraffin emollient creams

    Wider context from the report

    “Health care professionals in both hospital and community setting may not be aware of the potential fire hazard poised by emollient creams which contain a low level of paraffin ”
    Open source report

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below. The report was sent to Alliance Pharmaceuticals Limited; that does not assign responsibility.

    PFD Monitor interpretation

    Failure to display fire-risk warnings on all product packaging

    Wider context from the report

    “Warnings of such risks are not displayed on all product packaging ”
    Open source report

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below. The report was sent to Alliance Pharmaceuticals Limited; that does not assign responsibility.

    PFD Monitor interpretation

    Fire hazard from paraffin-based ointments and low-paraffin emollient creams

    Wider context from the report

    “Paraffin based ointments and emollient creams which contain a low level of paraffin pose a potential fire hazard risk ”
    Open source report

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Complete a Hydromol product-labelling review to improve warning prominence, clarity, content and consistency across paraffin concentrations.

    Verbatim wording from the response

    “We have completed a product labelling review to improve prominence, clarity and content as well as ensuring consistency across the Hydromol range, regardless of paraffin content. The revised product labelling, website and promotional materials is expected to be available throughout the remainder of 2018 and 2019.”

    Source location

    2018-0277-Response-by-Alliance-Pharmaceuticals-and-Bayer
    Page 1 · response
    Published 30 October 2018

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Undertake a cross-functional expert assessment of Hydromol labelling using information from the incident to identify further improvement opportunities.

    Verbatim wording from the response

    “We will undertake an assessment of the labelling throughout the remainder of this year, this activity will review all information from this event to determine any further opportunities for improvement of the current labelling. The assessment will be performed by a cross functional group of experts who have knowledge and experience of Hydromol and its use. We will implement any required changes to the product, product labelling or promotional materials which the risk assessment identifies. We will also apply required labelling amendments to marketed paraffin containing products, regardless of paraffin content.”

    Source location

    2018-0277-Response-by-Alliance-Pharmaceuticals-and-Bayer
    Page 2 · response
    Published 30 October 2018

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Review proposed Hydromol labelling changes with user groups to confirm that the intended safety message is understandable.

    Verbatim wording from the response

    “Furthermore, any proposed changes to the labelling will be reviewed by user groups who will support us in ensuring the intended message is understandable. We are also engaging with West Yorkshire Fire Service to ensure the mechanisms of risk are clearly stated on our labelling.”

    Source location

    2018-0277-Response-by-Alliance-Pharmaceuticals-and-Bayer
    Page 2 · response
    Published 30 October 2018

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Publish revised Hydromol labelling, website content and promotional materials incorporating improved fire-risk information.

    Verbatim wording from the response

    “We have completed a product labelling review to improve prominence, clarity and content as well as ensuring consistency across the Hydromol range, regardless of paraffin content. The revised product labelling, website and promotional materials is expected to be available throughout the remainder of 2018 and 2019.”

    Source location

    2018-0277-Response-by-Alliance-Pharmaceuticals-and-Bayer
    Page 1 · response
    Published 30 October 2018

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Engage West Yorkshire Fire Service to ensure Hydromol labelling clearly explains the mechanisms of fire risk.

    Verbatim wording from the response

    “Furthermore, any proposed changes to the labelling will be reviewed by user groups who will support us in ensuring the intended message is understandable. We are also engaging with West Yorkshire Fire Service to ensure the mechanisms of risk are clearly stated on our labelling.”

    Source location

    2018-0277-Response-by-Alliance-Pharmaceuticals-and-Bayer
    Page 2 · response
    Published 30 October 2018

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Work with the MHRA and PAGB to develop a consolidated fire-risk warning for all relevant product packaging across the industry.

    Verbatim wording from the response

    “We are proactively working with the MHRA and PAGB to ensure a consolidated warning is displayed on all product packaging, across industry. And we further commit to revisiting warnings on the product packaging, or any supporting processes, if additional information from the MHRA, trade bodies or any other expert groups becomes available.”

    Source location

    2018-0277-Response-by-Alliance-Pharmaceuticals-and-Bayer
    Page 2 · response
    Published 30 October 2018

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Update personnel communicating with healthcare professionals and the public on the assessment outcome and subsequent labelling changes.

    Verbatim wording from the response

    “Any and all personnel in contact with healthcare professionals and the general public will be updated appropriately to ensure communications are in line with, and convey, the correct message which communicates the outcome of the assessment and any subsequent labelling changes.”

    Source location

    2018-0277-Response-by-Alliance-Pharmaceuticals-and-Bayer
    Page 2 · response
    Published 30 October 2018

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Add a fire-risk warning to Hydromol product labelling, explaining ignition risks involving contaminated dressings, clothing and bedding.

    Verbatim wording from the response

    “The labelling now states:”

    Source location

    2018-0277-Response-by-Alliance-Pharmaceuticals-and-Bayer
    Page 1 · response
    Published 30 October 2018

    Open published response
Back to top

Published response patterns

Compared with other recipients in reports included in PFD Monitor

Describes published response evidence, not performance.

Published responses found

100%
100%All other recipients 58%
0%100%

How actions were described at the time

This respondent
22%33%44%
All other recipients
47%25%27%<1%<1%
  • Completed
  • In progress
  • Planned
  • Unclear
  • Partially completed

Statuses reflect what recipients said at the time. PFD Monitor does not verify whether actions happened.

Types of action described in responses

Percentages use all actions described by each group. An action may have more than one type, so percentages do not total 100%.

Information checked against published PFD reports and official responses · Data reviewed 7 Sep 2026 · About data quality and limitations

Data last updated 7 September 2026